- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02901314
My Recordable On-Demand Audio Discharge Instructions (MyROAD)
My Recordable On-Demand Audio Discharge Instructions (MyROAD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Main Campus
-
Cleveland, Ohio, United States
- Cleveland Clinic Fairview Hospital
-
Mayfield Heights, Ohio, United States, 44124
- Cleveland Clinic Hillcrest Hospital
-
Medina, Ohio, United States
- Cleveland Clinic Medina Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Not referred for cardiac transplantation or ventricular assist device during the index hospitalization,
- Minimum age 18 years (no upper age limit),
- Ability to read and write,
- Discharge to home or to a family member's home and has control of making self-care decisions,
- Willing to participate; which requires three (3) follow-up telephone calls post-discharge.
Exclusion Criteria:
- Chart documented psychiatric or cognitive conditions that limit ability to understand or adhere to self-care recommendations (Alzheimer's condition, dementia, schizophrenia, other neurological history that impairs memory),
- Plans to discharge to assisted living apartment/center, skilled nursing facility or hospice care center,
- Receiving home hospice or palliative care; or has a medical condition reflecting less than 1 year of survival (cachexia, end stage liver disease or cancer or non-ambulatory New York Heart Association functional class IV heart failure),
- Post-cardiac transplantation or ventricular assist device placement,
- Currently enrolled in another experimental heart failure research study,
- Chronic renal failure and receiving chronic hemodialysis therapy for an estimated glomerular filtration rate < 30 mL/minute/1.73 m2,
- A non-traditional form of heart failure (hypertrophic or restrictive forms of cardiomyopathy, congenital heart disease or Takotsubo cardiomyopathy).
- Wheelchair bound, uses a cane or walker, or unable to carry out physical activity, including walking,due to a chronic disability or documented medical condition.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MyRoad
Receives usual care heart failure education before discharge AND a card at discharge that provided pre-recorded audio messages that can be played back on-demand on 4 themes: heart failure signs/symptoms assessment, medications, activity and exercise and diet and a general message about the importance of follow-up post discharge and following the plan of care.
|
|
|
No Intervention: Usual care
Receives usual care heart failure education before discharge
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Patients Rehospitalized With Heart Failure
Time Frame: 30 day
|
Number of patients re-hospitalized with heart failure.
|
30 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Patients Scheduled for 7-day Follow-up Appointment With the Healthcare Provider Before Discharge
Time Frame: Discharge from hospital
|
Adherence to 7-day follow-up appointment with a healthcare provider; by medical record chart review
|
Discharge from hospital
|
|
Quality of Life (Health Status)
Time Frame: Baseline
|
Quality of life was measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ).
The KCCQ is a 23-item questionnaire that measures physical limitations, symptoms, self-efficacy, social interference and quality of life.
The KCCQ is a standardized score from 0 to 100 points.
A score of 0 is the lowest quality of life (poor) and score of 100 is the highest quality of life.
|
Baseline
|
|
Quality of Life (Health Status)
Time Frame: 45 day
|
Quality of life was measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ).
The KCCQ is a 23-item questionnaire that measures physical limitations, symptoms, self-efficacy, social interference and quality of life.
The KCCQ is a standardized score from 0 to 100 points.
A score of 0 is the lowest quality of life (poor) and score of 100 is the highest quality of life.
|
45 day
|
|
Symptoms
Time Frame: Baseline
|
29-item list of heart failure-related symptoms.
Patients were asked to consider any symptoms they experienced in the last 2 weeks and choose all that apply.
Patients could also check "do not weigh self" and "no signs or symptoms of anything abnormal".
The median [Q1, Q3] number of symptoms was reported between groups.
|
Baseline
|
|
Symptoms
Time Frame: 45 days
|
29-item list of heart failure-related symptoms.
Patients were asked to consider any symptoms they experienced in the last 2 weeks and choose all that apply.
Patients could also check "do not weigh self" and "no signs or symptoms of anything abnormal".
The median [Q1, Q3] number of symptoms was reported between groups.
|
45 days
|
|
Functional Status
Time Frame: Baseline
|
Duke Activity Status Index (DASI) is a 12-item questionnaire using Likert scale that determines a patient's ability to participate in common, everyday activities without difficulty including self-care activities (e.g., ambulation, housework, yard work, sexual relations, and recreational activities. This is a patient-reported tool that measures functional status in patients with heart failure. Scores range from 0 (no functional capacity = worst score) to 58.2 (highest functional capacity = best score). |
Baseline
|
|
Functional Status
Time Frame: 45 day
|
Duke Activity Status Index (DASI) is a 12-item questionnaire. This is a patient-reported tool that measures functional status in patients with heart failure. Patients were called by telephone and asked to rate their ability to do daily activities (e.g., personal care, ambulation, household tasks, sexual function, and recreation). Scores range from 0 (no functional capacity = worst score) to 58.2 (highest functional capacity = best score). |
45 day
|
|
Adherence to Activity Recommendations
Time Frame: Baseline
|
Modified PACE tool; used in previous research.
Patients were asked to self-report their perceived adherence to activity recommendations by selecting the option on a checklist that matched their activity level.
|
Baseline
|
|
Adherence to Activity Recommendations
Time Frame: 45 day
|
Modified PACE tool; used in previous research.
Patient's were contacted by telephone and asked to self-report their perceived adherence to activity recommendations.
|
45 day
|
|
Number of All-cause Re-hospitalization, Death, Left Ventricular Assist Device (LVAD), Cardiac Transplant (Composite Outcome)
Time Frame: 90 days
|
All-cause re-hospitalization, death, left ventricular assist device (LVAD), or cardiac transplant via medical record chart review; interview (telephone call).
|
90 days
|
|
Number of All-cause Re-hospitalization, Death, Left Ventricular Assist Device (LVAD), Cardiac Transplant (Composite Outcome)
Time Frame: 180 days
|
All-cause re-hospitalization, death, left ventricular assist device (LVAD), or cardiac transplant via medical record chart review; interview (telephone call).
|
180 days
|
|
Number of Patients Rehospitalized With Heart Failure
Time Frame: 45 days
|
Number of patients rehospitalized with heart failure via chart review; interview (telephone call).
|
45 days
|
|
Number of Patients Rehospitalized With Heart Failure
Time Frame: 90 days
|
Number of patients rehospitalized with heart failure via chart review
|
90 days
|
|
Number of Patients Rehospitalized With Heart Failure
Time Frame: 180 days
|
Number of patients rehospitalized with heart failure via chart review; interview (telephone call).
|
180 days
|
|
Number of Patients With All-cause Rehospitalization, Death or Emergency Department Visit
Time Frame: 180 days
|
Number of patients with all-cause rehospitalization, death, or emergency department visits within 180 days.
Information is obtained via medical record chart review.
|
180 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-122
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.